Request for Covid-19 Impact Assessment of this Report
The United States Dermal Filler and Botolinum Toxin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermal Filler and Botolinum Toxin market, reaching US$ million by the year 2028. As for the Europe Dermal Filler and Botolinum Toxin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dermal Filler and Botolinum Toxin players cover Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, and Anika Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Filler and Botolinum Toxin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Aesthetic Restoration
Wrinkle Reduction
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dermal Filler and Botolinum Toxin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dermal Filler and Botolinum Toxin by Country/Region, 2017, 2022 & 2028
2.2 Dermal Filler and Botolinum Toxin Segment by Type
2.2.1 Hyaluronic Acid Based Fillers
2.2.2 Non-Hyaluronic Acid Based Fillers
2.2.3 Botulinum Toxin
2.3 Dermal Filler and Botolinum Toxin Sales by Type
2.3.1 Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
2.3.2 Global Dermal Filler and Botolinum Toxin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Type (2017-2022)
2.4 Dermal Filler and Botolinum Toxin Segment by Application
2.4.1 Aesthetic Restoration
2.4.2 Wrinkle Reduction
2.5 Dermal Filler and Botolinum Toxin Sales by Application
2.5.1 Global Dermal Filler and Botolinum Toxin Sale Market Share by Application (2017-2022)
2.5.2 Global Dermal Filler and Botolinum Toxin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dermal Filler and Botolinum Toxin Sale Price by Application (2017-2022)
3 Global Dermal Filler and Botolinum Toxin by Company
3.1 Global Dermal Filler and Botolinum Toxin Breakdown Data by Company
3.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Company (2020-2022)
3.1.2 Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2020-2022)
3.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Company (2020-2022)
3.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Company (2020-2022)
3.2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2020-2022)
3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Company
3.4 Key Manufacturers Dermal Filler and Botolinum Toxin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermal Filler and Botolinum Toxin Product Location Distribution
3.4.2 Players Dermal Filler and Botolinum Toxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dermal Filler and Botolinum Toxin by Geographic Region
4.1 World Historic Dermal Filler and Botolinum Toxin Market Size by Geographic Region (2017-2022)
4.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Geographic Region
4.2 World Historic Dermal Filler and Botolinum Toxin Market Size by Country/Region (2017-2022)
4.2.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Country/Region
4.3 Americas Dermal Filler and Botolinum Toxin Sales Growth
4.4 APAC Dermal Filler and Botolinum Toxin Sales Growth
4.5 Europe Dermal Filler and Botolinum Toxin Sales Growth
4.6 Middle East & Africa Dermal Filler and Botolinum Toxin Sales Growth
5 Americas
5.1 Americas Dermal Filler and Botolinum Toxin Sales by Country
5.1.1 Americas Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)
5.1.2 Americas Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)
5.2 Americas Dermal Filler and Botolinum Toxin Sales by Type
5.3 Americas Dermal Filler and Botolinum Toxin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermal Filler and Botolinum Toxin Sales by Region
6.1.1 APAC Dermal Filler and Botolinum Toxin Sales by Region (2017-2022)
6.1.2 APAC Dermal Filler and Botolinum Toxin Revenue by Region (2017-2022)
6.2 APAC Dermal Filler and Botolinum Toxin Sales by Type
6.3 APAC Dermal Filler and Botolinum Toxin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dermal Filler and Botolinum Toxin by Country
7.1.1 Europe Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)
7.1.2 Europe Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)
7.2 Europe Dermal Filler and Botolinum Toxin Sales by Type
7.3 Europe Dermal Filler and Botolinum Toxin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermal Filler and Botolinum Toxin by Country
8.1.1 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)
8.2 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Type
8.3 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermal Filler and Botolinum Toxin
10.3 Manufacturing Process Analysis of Dermal Filler and Botolinum Toxin
10.4 Industry Chain Structure of Dermal Filler and Botolinum Toxin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dermal Filler and Botolinum Toxin Distributors
11.3 Dermal Filler and Botolinum Toxin Customer
12 World Forecast Review for Dermal Filler and Botolinum Toxin by Geographic Region
12.1 Global Dermal Filler and Botolinum Toxin Market Size Forecast by Region
12.1.1 Global Dermal Filler and Botolinum Toxin Forecast by Region (2023-2028)
12.1.2 Global Dermal Filler and Botolinum Toxin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dermal Filler and Botolinum Toxin Forecast by Type
12.7 Global Dermal Filler and Botolinum Toxin Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Dermal Filler and Botolinum Toxin Product Offered
13.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Galderma
13.2.1 Galderma Company Information
13.2.2 Galderma Dermal Filler and Botolinum Toxin Product Offered
13.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Galderma Main Business Overview
13.2.5 Galderma Latest Developments
13.3 Merz Pharma GmbH & Co. KGaA
13.3.1 Merz Pharma GmbH & Co. KGaA Company Information
13.3.2 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Offered
13.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merz Pharma GmbH & Co. KGaA Main Business Overview
13.3.5 Merz Pharma GmbH & Co. KGaA Latest Developments
13.4 Anika Therapeutics
13.4.1 Anika Therapeutics Company Information
13.4.2 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Offered
13.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Anika Therapeutics Main Business Overview
13.4.5 Anika Therapeutics Latest Developments
13.5 Suneva Medical
13.5.1 Suneva Medical Company Information
13.5.2 Suneva Medical Dermal Filler and Botolinum Toxin Product Offered
13.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Suneva Medical Main Business Overview
13.5.5 Suneva Medical Latest Developments
13.6 Contura
13.6.1 Contura Company Information
13.6.2 Contura Dermal Filler and Botolinum Toxin Product Offered
13.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Contura Main Business Overview
13.6.5 Contura Latest Developments
13.7 HUGEL
13.7.1 HUGEL Company Information
13.7.2 HUGEL Dermal Filler and Botolinum Toxin Product Offered
13.7.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 HUGEL Main Business Overview
13.7.5 HUGEL Latest Developments
13.8 Grex Pharma
13.8.1 Grex Pharma Company Information
13.8.2 Grex Pharma Dermal Filler and Botolinum Toxin Product Offered
13.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Grex Pharma Main Business Overview
13.8.5 Grex Pharma Latest Developments
13.9 Daewoong Pharmaceuticals
13.9.1 Daewoong Pharmaceuticals Company Information
13.9.2 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Offered
13.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Daewoong Pharmaceuticals Main Business Overview
13.9.5 Daewoong Pharmaceuticals Latest Developments
13.10 Medy-Tox
13.10.1 Medy-Tox Company Information
13.10.2 Medy-Tox Dermal Filler and Botolinum Toxin Product Offered
13.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Medy-Tox Main Business Overview
13.10.5 Medy-Tox Latest Developments
13.11 TEOXANE Laboratories
13.11.1 TEOXANE Laboratories Company Information
13.11.2 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Offered
13.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 TEOXANE Laboratories Main Business Overview
13.11.5 TEOXANE Laboratories Latest Developments
13.12 SciVision Biotech
13.12.1 SciVision Biotech Company Information
13.12.2 SciVision Biotech Dermal Filler and Botolinum Toxin Product Offered
13.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SciVision Biotech Main Business Overview
13.12.5 SciVision Biotech Latest Developments
14 Research Findings and Conclusion
Table 1. Dermal Filler and Botolinum Toxin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dermal Filler and Botolinum Toxin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Hyaluronic Acid Based Fillers
Table 4. Major Players of Non-Hyaluronic Acid Based Fillers
Table 5. Major Players of Botulinum Toxin
Table 6. Global Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)
Table 7. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
Table 8. Global Dermal Filler and Botolinum Toxin Revenue by Type (2017-2022) & ($ million)
Table 9. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2017-2022)
Table 10. Global Dermal Filler and Botolinum Toxin Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)
Table 12. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Table 13. Global Dermal Filler and Botolinum Toxin Revenue by Application (2017-2022)
Table 14. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2017-2022)
Table 15. Global Dermal Filler and Botolinum Toxin Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Dermal Filler and Botolinum Toxin Sales by Company (2020-2022) & (K MT)
Table 17. Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2020-2022)
Table 18. Global Dermal Filler and Botolinum Toxin Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2020-2022)
Table 20. Global Dermal Filler and Botolinum Toxin Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Dermal Filler and Botolinum Toxin Producing Area Distribution and Sales Area
Table 22. Players Dermal Filler and Botolinum Toxin Products Offered
Table 23. Dermal Filler and Botolinum Toxin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Dermal Filler and Botolinum Toxin Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Dermal Filler and Botolinum Toxin Sales Market Share Geographic Region (2017-2022)
Table 28. Global Dermal Filler and Botolinum Toxin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Dermal Filler and Botolinum Toxin Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Dermal Filler and Botolinum Toxin Sales Market Share by Country/Region (2017-2022)
Table 32. Global Dermal Filler and Botolinum Toxin Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)
Table 35. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)
Table 36. Americas Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)
Table 38. Americas Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)
Table 39. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
Table 40. Americas Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)
Table 41. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Table 42. APAC Dermal Filler and Botolinum Toxin Sales by Region (2017-2022) & (K MT)
Table 43. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Region (2017-2022)
Table 44. APAC Dermal Filler and Botolinum Toxin Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2017-2022)
Table 46. APAC Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)
Table 47. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
Table 48. APAC Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)
Table 49. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Table 50. Europe Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)
Table 51. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)
Table 52. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)
Table 54. Europe Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)
Table 55. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
Table 56. Europe Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)
Table 57. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Dermal Filler and Botolinum Toxin
Table 67. Key Market Challenges & Risks of Dermal Filler and Botolinum Toxin
Table 68. Key Industry Trends of Dermal Filler and Botolinum Toxin
Table 69. Dermal Filler and Botolinum Toxin Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Dermal Filler and Botolinum Toxin Distributors List
Table 72. Dermal Filler and Botolinum Toxin Customer List
Table 73. Global Dermal Filler and Botolinum Toxin Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Dermal Filler and Botolinum Toxin Sales Market Forecast by Region
Table 75. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Dermal Filler and Botolinum Toxin Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Dermal Filler and Botolinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Dermal Filler and Botolinum Toxin Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Dermal Filler and Botolinum Toxin Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Dermal Filler and Botolinum Toxin Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Dermal Filler and Botolinum Toxin Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Application (2023-2028)
Table 93. Allergan Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergan Dermal Filler and Botolinum Toxin Product Offered
Table 95. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. Allergan Main Business
Table 97. Allergan Latest Developments
Table 98. Galderma Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 99. Galderma Dermal Filler and Botolinum Toxin Product Offered
Table 100. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 101. Galderma Main Business
Table 102. Galderma Latest Developments
Table 103. Merz Pharma GmbH & Co. KGaA Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 104. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Offered
Table 105. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 106. Merz Pharma GmbH & Co. KGaA Main Business
Table 107. Merz Pharma GmbH & Co. KGaA Latest Developments
Table 108. Anika Therapeutics Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 109. Anika Therapeutics Dermal Filler and Botolinum Toxin Product Offered
Table 110. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 111. Anika Therapeutics Main Business
Table 112. Anika Therapeutics Latest Developments
Table 113. Suneva Medical Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 114. Suneva Medical Dermal Filler and Botolinum Toxin Product Offered
Table 115. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 116. Suneva Medical Main Business
Table 117. Suneva Medical Latest Developments
Table 118. Contura Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 119. Contura Dermal Filler and Botolinum Toxin Product Offered
Table 120. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 121. Contura Main Business
Table 122. Contura Latest Developments
Table 123. HUGEL Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 124. HUGEL Dermal Filler and Botolinum Toxin Product Offered
Table 125. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 126. HUGEL Main Business
Table 127. HUGEL Latest Developments
Table 128. Grex Pharma Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 129. Grex Pharma Dermal Filler and Botolinum Toxin Product Offered
Table 130. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 131. Grex Pharma Main Business
Table 132. Grex Pharma Latest Developments
Table 133. Daewoong Pharmaceuticals Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 134. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Offered
Table 135. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 136. Daewoong Pharmaceuticals Main Business
Table 137. Daewoong Pharmaceuticals Latest Developments
Table 138. Medy-Tox Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 139. Medy-Tox Dermal Filler and Botolinum Toxin Product Offered
Table 140. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 141. Medy-Tox Main Business
Table 142. Medy-Tox Latest Developments
Table 143. TEOXANE Laboratories Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 144. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Offered
Table 145. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 146. TEOXANE Laboratories Main Business
Table 147. TEOXANE Laboratories Latest Developments
Table 148. SciVision Biotech Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 149. SciVision Biotech Dermal Filler and Botolinum Toxin Product Offered
Table 150. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 151. SciVision Biotech Main Business
Table 152. SciVision Biotech Latest Developments
List of Figures
Figure 1. Picture of Dermal Filler and Botolinum Toxin
Figure 2. Dermal Filler and Botolinum Toxin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermal Filler and Botolinum Toxin Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Dermal Filler and Botolinum Toxin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dermal Filler and Botolinum Toxin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Hyaluronic Acid Based Fillers
Figure 10. Product Picture of Non-Hyaluronic Acid Based Fillers
Figure 11. Product Picture of Botulinum Toxin
Figure 12. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type in 2021
Figure 13. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2017-2022)
Figure 14. Dermal Filler and Botolinum Toxin Consumed in Aesthetic Restoration
Figure 15. Global Dermal Filler and Botolinum Toxin Market: Aesthetic Restoration (2017-2022) & (K MT)
Figure 16. Dermal Filler and Botolinum Toxin Consumed in Wrinkle Reduction
Figure 17. Global Dermal Filler and Botolinum Toxin Market: Wrinkle Reduction (2017-2022) & (K MT)
Figure 18. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)
Figure 19. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application in 2021
Figure 20. Dermal Filler and Botolinum Toxin Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company in 2021
Figure 22. Global Dermal Filler and Botolinum Toxin Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Geographic Region in 2021
Figure 24. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2017-2022)
Figure 25. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Country/Region in 2021
Figure 26. Americas Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)
Figure 27. Americas Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)
Figure 28. APAC Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)
Figure 29. APAC Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)
Figure 30. Europe Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)
Figure 31. Europe Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)
Figure 33. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)
Figure 34. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021
Figure 35. Americas Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021
Figure 36. United States Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Region in 2021
Figure 41. APAC Dermal Filler and Botolinum Toxin Revenue Market Share by Regions in 2021
Figure 42. China Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021
Figure 49. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021
Figure 50. Germany Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021
Figure 57. Egypt Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Dermal Filler and Botolinum Toxin in 2021
Figure 63. Manufacturing Process Analysis of Dermal Filler and Botolinum Toxin
Figure 64. Industry Chain Structure of Dermal Filler and Botolinum Toxin
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...